Animal Myristoylomics Analysis: Comprehensive Profiling of Protein Myristoylation by Advanced Mass S

Animal myristoylomics analysis is a specialized proteomics service that enables global identification and quantification of protein myristoylation in animal tissues, cells, and model organisms. By combining metabolic labeling with alkyne-functionalized myristic acid analogs, click chemistry enrichment, and high-resolution LC-MS/MS, this technology reveals the full landscape of N-terminal and lysine myristoylation events that regulate membrane targeting, signal transduction, and disease progression. Researchers in cancer biology, neuroscience, immunology, and drug development rely on myristoylomics to uncover lipidation-dependent mechanisms with site-level precision.

Technical Overview

Myristoylation is a fundamental lipid post-translational modification (PTM) in which a 14-carbon saturated fatty acid, myristate, is covalently attached to specific amino acid residues of proteins. Unlike palmitoylation, myristoylation is generally a stable, quasi-irreversible modification that plays a decisive role in controlling protein localization, membrane association, conformational state, and protein-protein interactions. In animals, dysregulation of myristoylation has been directly linked to oncogenesis, viral infection, neurodegeneration, immune dysfunction, and metabolic disease, making the systematic study of this modification essential for modern life science research.

Protein myristoylation occurs in two principal forms. Canonical N-terminal myristoylation is catalyzed by N-myristoyltransferase (NMT), which attaches myristate to the alpha-amino group of an N-terminal glycine residue exposed after co-translational removal of the initiator methionine. This modification is found on more than one hundred annotated animal proteins, including members of the Src family kinases, G-protein alpha subunits, calcineurin B, MARCKS, and many apoptotic regulators. In addition, non-canonical lysine myristoylation has been discovered on internal lysine residues of proteins such as TNF-alpha, IFITM3, and SIRT6, expanding the functional scope of this PTM beyond membrane anchoring to include enzymatic activity regulation and cytokine biology.

Animal myristoylomics analysis refers to the large-scale, unbiased profiling of all myristoylated proteins and their modification sites within a biological system. Because myristoylated peptides are low-abundance, hydrophobic, and chemically labile, their detection requires dedicated enrichment strategies combined with state-of-the-art mass spectrometry. A typical analytical workflow consists of metabolic or chemical labeling, bioorthogonal click conjugation, affinity enrichment, enzymatic digestion, nanoLC-MS/MS measurement, database searching with myristoylation as a variable modification, and comprehensive bioinformatic interpretation. This integrated approach enables researchers to move from single-protein studies toward systems-level understanding of myristoylation networks in animal models.

Testing Samples

Animal Tissue Samples

Fresh-frozen or fixed tissues collected from mammalian, avian, aquatic, and invertebrate species are accepted for myristoylomics analysis. Commonly analyzed tissues include brain, liver, heart, kidney, spleen, lung, skeletal muscle, adipose tissue, thymus, and tumor xenografts. Tissues should be dissected rapidly, rinsed to remove blood contamination, snap-frozen in liquid nitrogen, and shipped on dry ice to preserve the integrity of labile lipid modifications.

Primary Cells and Cultured Cell Lines

Animal-derived primary cells (neurons, hepatocytes, macrophages, T cells, cardiomyocytes) and established cell lines are highly suitable for metabolic labeling workflows, in which alkyne-tagged myristic acid analogs are directly incorporated into nascent myristoylated proteins during culture. This sample type provides the highest labeling efficiency and the cleanest background for site-level myristoylation mapping.

Model Organism Samples

Samples from widely used animal models, including mouse, rat, zebrafish, Drosophila, and C. elegans, are fully supported at multiple developmental stages. Whole-organism homogenates, dissected organs, developmental stage pools, and tissue-specific samples can all be processed following optimized extraction protocols tailored to each species.

Biofluids and Subcellular Fractions

Plasma, serum, cerebrospinal fluid, and isolated membrane fractions, lipid rafts, exosomes, and synaptic preparations can be analyzed to investigate myristoylation in circulating and compartmentalized proteomes. Enriched membrane fractions are particularly valuable because most N-terminally myristoylated proteins partition into cellular membranes.

Testing Items

Animal myristoylomics analysis covers a complete panel of qualitative, quantitative, and functional testing items designed to answer diverse biological questions:

• Global identification of N-terminally myristoylated proteins and their modified glycine residues
• Site-specific mapping of non-canonical lysine myristoylation events
• Quantitative comparison of myristoylation levels between experimental groups (control vs. disease, wild-type vs. knockout, treated vs. untreated)
• Detection of conditionally regulated myristoylation, including apoptotic proteolytic reveals of cryptic N-terminal glycine sites
• Assessment of N-myristoyltransferase (NMT) substrate occupancy and enzyme activity modulation
• Integrated myristoylome and total proteome profiling to distinguish changes in modification stoichiometry from changes in protein abundance
• Competitive profiling of endogenous versus analog-derived myristoylation to validate substrate authenticity
• Functional annotation of myristoylated proteins, including Gene Ontology (GO), KEGG pathway, domain, and motif enrichment analyses
• Construction of myristoylation-dependent protein interaction and signaling networks

Testing Methods

Metabolic Labeling with Bioorthogonal Myristic Acid Analogs

The gold-standard approach for myristoylomics employs omega-alkyne or azide-functionalized myristic acid probes, such as terminal alkyne myristate (YnMyr) or azido-myristate. Living cells, primary cultures, or model organisms are metabolically fed with the analog, which is accepted by endogenous NMT and incorporated into bona fide myristoylation sites in place of natural myristate. Parallel incubation with unmodified myristic acid serves as a negative control to filter nonspecific signals.

Click Chemistry Enrichment

Following lysis, analog-labeled proteins undergo copper-catalyzed azide-alkyne cycloaddition (CuAAC) with biotin or a cleavable biotin-linker reagent. Labeled proteins or tryptic peptides are then captured on streptavidin resin with extremely high affinity, effectively enriching the myristoylated subproteome from a complex background. Cleavable linker chemistries allow specific elution of enriched peptides, substantially reducing carryover of abundant non-modified proteins and improving detection sensitivity.

Antibody-Based and Chemical Enrichment Strategies

For lysine myristoylation profiling, pan anti-myristoyl-lysine antibody immunoprecipitation provides targeted enrichment of K-myristoylated peptides. In samples where metabolic labeling is not feasible, such as clinical tissue specimens, chemical derivatization and acyl-resin capture strategies can be adapted to capture thioester-free amide-linked myristoyl groups on N-terminal glycine residues.

High-Resolution LC-MS/MS Analysis

Enriched peptides are separated by nano-flow reversed-phase liquid chromatography and analyzed on high-resolution tandem mass spectrometers, including Orbitrap and Q-TOF platforms. Both HCD and ETD/EThcD fragmentation schemes are applied to preserve site-determining fragment ions, particularly for large hydrophobic N-terminal myristoylglycine peptides. Myristoylation is searched as a variable modification with a characteristic mass shift of +210.1984 Da on protein N-terminal glycine or lysine residues, with strict false discovery rate control at the peptide, protein, and modification-site levels.

Quantification and Bioinformatics

Relative quantification is achieved through label-free intensity comparison, SILAC with heavy-isotope myristate, or isobaric chemical labeling such as TMT, depending on experimental design and sample type. The bioinformatics pipeline delivers modification-site localization probabilities, motif and sequence-context analysis, subcellular localization prediction, pathway and network mapping, statistical comparison across groups, and publication-ready visualization including volcano plots, heat maps, and interaction networks.

Applications

Animal myristoylomics analysis supports a wide spectrum of research and development applications across basic biology and translational medicine:

• Cancer biology: Profiling of NMT-dependent oncogenic signaling, Src family kinase activation, and apoptotic "myristoylome switching" to identify tumor-specific lipidation events and biomarker candidates
• Drug discovery: Target engagement assays and global substrate occupancy measurements for NMT inhibitors under preclinical development, supporting pharmacodynamic biomarker discovery
• Infectious disease research: Characterization of host and pathogen myristoylated proteins during viral and parasitic infection, including viral proteins that exploit host NMT for maturation
• Neuroscience: Investigation of myristoylated neuronal proteins, calcium sensor trafficking, synaptic signaling, and lipidation defects associated with neurodegenerative conditions
• Immunology: Analysis of lysine myristoylation on immune effectors such as interferon-induced transmembrane proteins and inflammatory cytokines under activation conditions
• Developmental biology: Stage-resolved myristoylome profiling in zebrafish and other models to define lipidation programs governing embryogenesis and organogenesis
• Livestock and veterinary science: Comparative myristoylation studies in economically important animal species to support breeding, nutrition, and disease-resistance research
• Metabolic research: Elucidation of how fatty acid availability and lipid metabolism reshape the myristoylated proteome under dietary or pharmacological interventions

FAQ

What is the recommended sample amount for myristoylomics analysis?

For cell-based metabolic labeling experiments, approximately 10^7 to 10^8 cells per condition are recommended. For animal tissues, 50-200 mg of fresh-frozen material per sample typically provides sufficient coverage. Lower-input protocols can be discussed for rare or precious specimens, and pilot feasibility assessments are available.

How are genuine myristoylation events distinguished from palmitoylation or other acylation signals?

Myristoylation is an amide-linked modification that is resistant to hydroxylamine treatment, whereas S-palmitoylation is a thioester linkage that is hydroxylamine-sensitive. Combined with the strict N-terminal glycine sequence rule, the use of chain-length-specific myristic acid analogs, and competition controls with natural myristate, the workflow confidently discriminates true myristoylation from other lipidation events.

Can both N-terminal and lysine myristoylation be detected in the same project?

Yes. Search parameters include both N-terminal glycine and internal lysine myristoylation, and orthogonal enrichment modules (analog labeling for N-terminal events, anti-myristoyl-lysine immunoenrichment for K-modification) can be combined in a multi-pronged experimental design for comprehensive coverage.

Is quantitative comparison between experimental groups possible?

Absolutely. Label-free quantification, SILAC-based strategies, and isobaric mass tagging are all supported for pairwise or multi-group comparisons, allowing identification of differentially myristoylated proteins and sites with statistical confidence.

How should samples be prepared and shipped?

Tissues should be snap-frozen in liquid nitrogen immediately after collection and shipped on dry ice. Cells for metabolic labeling can be shipped as frozen pellets or cultured directly in the laboratory according to protocol. Avoid repeated freeze-thaw cycles, and include protease and deacylase inhibitors during all lysis steps to preserve modification integrity.

What deliverables are provided at the end of the project?

A complete data package is provided, including the full list of identified myristoylated proteins and sites with localization probabilities, quantitative matrices across conditions, volcano plots and heat maps of differential events, GO and KEGG enrichment results, protein interaction network maps, raw MS files, detailed methodology, and a comprehensive analysis report suitable for publication.

What is the typical project timeline?

Standard myristoylomics projects, from sample receipt to final bioinformatics report, generally require 4 to 8 weeks depending on sample type, number of experimental groups, and whether additional validation assays such as targeted PRM verification are included.